FDA Inspection 1305038 — NeoChild, LLC
The FDA completed an inspection of NeoChild, LLC on February 11, 2026 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 11, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Oklahoma City, OK (United States)